[18F]FDOPA PET/CT is superior to [68Ga]DOTATOC PET/CT in diagnostic imaging of pheochromocytoma

Abstract Background Both [18F]FDOPA (FDOPA) and [68Ga]DOTATOC PET/CT (DOTATOC) are widely used for detection of pheochromocytomas/paraganglioma (PPGL). However, direct comparisons of the performance of the two tracers are only available in small series. We conducted a retrospective comparative analy...

Full description

Bibliographic Details
Main Authors: Peter Iversen, Stine Kramer, Andreas Ebbehoj, Esben Søndergaard, Kirstine Stochholm, Per Løgstrup Poulsen, Karin Hjorthaug
Format: Article
Language:English
Published: SpringerOpen 2023-12-01
Series:EJNMMI Research
Subjects:
Online Access:https://doi.org/10.1186/s13550-023-01056-4
_version_ 1827399331000352768
author Peter Iversen
Stine Kramer
Andreas Ebbehoj
Esben Søndergaard
Kirstine Stochholm
Per Løgstrup Poulsen
Karin Hjorthaug
author_facet Peter Iversen
Stine Kramer
Andreas Ebbehoj
Esben Søndergaard
Kirstine Stochholm
Per Løgstrup Poulsen
Karin Hjorthaug
author_sort Peter Iversen
collection DOAJ
description Abstract Background Both [18F]FDOPA (FDOPA) and [68Ga]DOTATOC PET/CT (DOTATOC) are widely used for detection of pheochromocytomas/paraganglioma (PPGL). However, direct comparisons of the performance of the two tracers are only available in small series. We conducted a retrospective comparative analysis of FDOPA and DOTATOC to assess their sensitivity and accuracy in detecting PPGL when administered based on suspicion of PPGL. We consecutively included patients referred on suspicion of PPGL or PPGL recurrence who were scanned with both FDOPA and DOTATOC. Both scans were reviewed retrospectively by two experienced observers, who were blinded to the final diagnosis. The assessment was made both visually and quantitatively. The final diagnosis was primarily based on pathology. Results In total, 113 patients were included (97 suspected of primary PPGL and 16 suspected of recurrence). Of the 97 patients, 51 had pheochromocytomas (PCC) (in total 55 lesions) and 6 had paragangliomas (PGL) (in total 7 lesions). FDOPA detected and correctly localized all 55 PCC, while DOTATOC only detected 25 (sensitivity 100% vs. 49%, p < 0.0001; specificity 95% vs. 98%, p = 1.00). The negative predictive value (100% vs. 63%, p < 0.001) and diagnostic accuracy (98% vs. 70%, p < 0.01) were higher for FDOPA compared to DOTATOC. FDOPA identified 6 of 6 patients with hormone producing PGL, of which one was negative on DOTATOC. Diagnostic performances of FDOPA and DOTATOC were similar in the 16 patients with previous PPGL suspected of recurrence. Conclusions FDOPA is superior to DOTATOC for localization of PCC. In contrast to DOTATOC, FDOPA also identified all PGL but with a limited number of patient cases.
first_indexed 2024-03-08T19:43:24Z
format Article
id doaj.art-6342e1f9b895447996544d06d52995b5
institution Directory Open Access Journal
issn 2191-219X
language English
last_indexed 2024-03-08T19:43:24Z
publishDate 2023-12-01
publisher SpringerOpen
record_format Article
series EJNMMI Research
spelling doaj.art-6342e1f9b895447996544d06d52995b52023-12-24T12:29:03ZengSpringerOpenEJNMMI Research2191-219X2023-12-0113111010.1186/s13550-023-01056-4[18F]FDOPA PET/CT is superior to [68Ga]DOTATOC PET/CT in diagnostic imaging of pheochromocytomaPeter Iversen0Stine Kramer1Andreas Ebbehoj2Esben Søndergaard3Kirstine Stochholm4Per Løgstrup Poulsen5Karin Hjorthaug6Department of Nuclear Medicine and PET Centre, Aarhus University HospitalDepartment of Nuclear Medicine and PET Centre, Aarhus University HospitalDepartment of Endocrinology and Internal Medicine, Aarhus University HospitalDepartment of Endocrinology and Internal Medicine, Aarhus University HospitalDepartment of Endocrinology and Internal Medicine, Aarhus University HospitalDepartment of Endocrinology and Internal Medicine, Aarhus University HospitalDepartment of Nuclear Medicine and PET Centre, Aarhus University HospitalAbstract Background Both [18F]FDOPA (FDOPA) and [68Ga]DOTATOC PET/CT (DOTATOC) are widely used for detection of pheochromocytomas/paraganglioma (PPGL). However, direct comparisons of the performance of the two tracers are only available in small series. We conducted a retrospective comparative analysis of FDOPA and DOTATOC to assess their sensitivity and accuracy in detecting PPGL when administered based on suspicion of PPGL. We consecutively included patients referred on suspicion of PPGL or PPGL recurrence who were scanned with both FDOPA and DOTATOC. Both scans were reviewed retrospectively by two experienced observers, who were blinded to the final diagnosis. The assessment was made both visually and quantitatively. The final diagnosis was primarily based on pathology. Results In total, 113 patients were included (97 suspected of primary PPGL and 16 suspected of recurrence). Of the 97 patients, 51 had pheochromocytomas (PCC) (in total 55 lesions) and 6 had paragangliomas (PGL) (in total 7 lesions). FDOPA detected and correctly localized all 55 PCC, while DOTATOC only detected 25 (sensitivity 100% vs. 49%, p < 0.0001; specificity 95% vs. 98%, p = 1.00). The negative predictive value (100% vs. 63%, p < 0.001) and diagnostic accuracy (98% vs. 70%, p < 0.01) were higher for FDOPA compared to DOTATOC. FDOPA identified 6 of 6 patients with hormone producing PGL, of which one was negative on DOTATOC. Diagnostic performances of FDOPA and DOTATOC were similar in the 16 patients with previous PPGL suspected of recurrence. Conclusions FDOPA is superior to DOTATOC for localization of PCC. In contrast to DOTATOC, FDOPA also identified all PGL but with a limited number of patient cases.https://doi.org/10.1186/s13550-023-01056-4FDOPADOTATOCPheochromocytomaParagangliomaPETPPGL
spellingShingle Peter Iversen
Stine Kramer
Andreas Ebbehoj
Esben Søndergaard
Kirstine Stochholm
Per Løgstrup Poulsen
Karin Hjorthaug
[18F]FDOPA PET/CT is superior to [68Ga]DOTATOC PET/CT in diagnostic imaging of pheochromocytoma
EJNMMI Research
FDOPA
DOTATOC
Pheochromocytoma
Paraganglioma
PET
PPGL
title [18F]FDOPA PET/CT is superior to [68Ga]DOTATOC PET/CT in diagnostic imaging of pheochromocytoma
title_full [18F]FDOPA PET/CT is superior to [68Ga]DOTATOC PET/CT in diagnostic imaging of pheochromocytoma
title_fullStr [18F]FDOPA PET/CT is superior to [68Ga]DOTATOC PET/CT in diagnostic imaging of pheochromocytoma
title_full_unstemmed [18F]FDOPA PET/CT is superior to [68Ga]DOTATOC PET/CT in diagnostic imaging of pheochromocytoma
title_short [18F]FDOPA PET/CT is superior to [68Ga]DOTATOC PET/CT in diagnostic imaging of pheochromocytoma
title_sort 18f fdopa pet ct is superior to 68ga dotatoc pet ct in diagnostic imaging of pheochromocytoma
topic FDOPA
DOTATOC
Pheochromocytoma
Paraganglioma
PET
PPGL
url https://doi.org/10.1186/s13550-023-01056-4
work_keys_str_mv AT peteriversen 18ffdopapetctissuperiorto68gadotatocpetctindiagnosticimagingofpheochromocytoma
AT stinekramer 18ffdopapetctissuperiorto68gadotatocpetctindiagnosticimagingofpheochromocytoma
AT andreasebbehoj 18ffdopapetctissuperiorto68gadotatocpetctindiagnosticimagingofpheochromocytoma
AT esbensøndergaard 18ffdopapetctissuperiorto68gadotatocpetctindiagnosticimagingofpheochromocytoma
AT kirstinestochholm 18ffdopapetctissuperiorto68gadotatocpetctindiagnosticimagingofpheochromocytoma
AT perløgstruppoulsen 18ffdopapetctissuperiorto68gadotatocpetctindiagnosticimagingofpheochromocytoma
AT karinhjorthaug 18ffdopapetctissuperiorto68gadotatocpetctindiagnosticimagingofpheochromocytoma